FineMark National Bank & Trust Buys 554 Shares of The Allstate Corporation $ALL

FineMark National Bank & Trust increased its stake in The Allstate Corporation (NYSE:ALL) by 3.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,821 shares of the insurance provider’s stock after buying an additional 554 shares during the quarter. FineMark National Bank & Trust’s holdings in Allstate were worth $2,984,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the company. Arlington Trust Co LLC lifted its holdings in shares of Allstate by 261.8% in the 2nd quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 89 shares during the last quarter. Clearstead Trust LLC raised its position in Allstate by 3,800.0% in the 2nd quarter. Clearstead Trust LLC now owns 156 shares of the insurance provider’s stock worth $31,000 after purchasing an additional 152 shares during the period. Caitong International Asset Management Co. Ltd lifted its stake in Allstate by 315.0% in the second quarter. Caitong International Asset Management Co. Ltd now owns 166 shares of the insurance provider’s stock worth $33,000 after purchasing an additional 126 shares during the last quarter. Hilltop National Bank purchased a new position in shares of Allstate during the second quarter valued at approximately $34,000. Finally, Chilton Capital Management LLC bought a new position in shares of Allstate during the second quarter valued at approximately $38,000. Institutional investors own 76.47% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Barclays reissued an “underweight” rating and set a $198.00 price target (up from $188.00) on shares of Allstate in a research note on Thursday, July 31st. Roth Capital set a $230.00 target price on shares of Allstate and gave the company a “buy” rating in a research note on Friday, September 26th. Wells Fargo & Company upped their price target on shares of Allstate from $202.00 to $216.00 and gave the stock an “equal weight” rating in a report on Friday, November 7th. Keefe, Bruyette & Woods lifted their price objective on shares of Allstate from $246.00 to $250.00 and gave the company an “outperform” rating in a report on Tuesday, November 11th. Finally, BMO Capital Markets boosted their price objective on shares of Allstate from $235.00 to $244.00 and gave the company an “outperform” rating in a research report on Friday, November 7th. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $237.64.

Allstate Stock Performance

Shares of Allstate stock opened at $209.89 on Thursday. The Allstate Corporation has a 12 month low of $176.00 and a 12 month high of $215.70. The stock’s fifty day moving average price is $202.92 and its 200-day moving average price is $201.91. The firm has a market cap of $54.92 billion, a P/E ratio of 9.87, a P/E/G ratio of 0.69 and a beta of 0.35. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.37.

Allstate (NYSE:ALL) last posted its earnings results on Wednesday, November 5th. The insurance provider reported $11.17 EPS for the quarter, beating analysts’ consensus estimates of $5.48 by $5.69. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The business had revenue of $17.26 billion for the quarter, compared to the consensus estimate of $16.59 billion. During the same quarter last year, the firm posted $3.91 EPS. The company’s revenue for the quarter was up 3.8% on a year-over-year basis. On average, equities research analysts expect that The Allstate Corporation will post 18.74 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Allstate news, insider Suren Gupta sold 400 shares of the stock in a transaction on Monday, November 17th. The stock was sold at an average price of $215.22, for a total transaction of $86,088.00. Following the sale, the insider owned 100,646 shares of the company’s stock, valued at approximately $21,661,032.12. This trade represents a 0.40% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.70% of the stock is currently owned by corporate insiders.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.